La sopravvivenza dei pazienti oncologici in Italia: Survival of cancer patients in Italy

Translated title of the contribution: Survival of cancer patients in Italy

Vincenzo Coviello, Carlotta Buzzoni, Mario Fusco, Alessandro Barchielli, Francesco Cuccaro, Roberta De Angelis, Adriano Giacomin, Stefano Luminari, Giorgia Randi, Lucia Mangone, AIRTUM Working Group, Rosa Filiberti

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVES: Population-based survival statistics are fundamental to assess the efficacy of services offered to improve cancer patients' prognosis. This study aims to update cancer survival estimates for the Italian population, as well as provide new measures, such as the crude probability of death, which takes into account the possibility of dying from causes other than cancer, and the change in life expectancy after a cancer diagnosis, to properly address various questions.RESULTS: The study includes 1,932,450 cancer cases detected by the Network of Italian Cancer Registries (AIRTUM) from 1994 to 2011 and provides estimates for 38 cancer sites and for allsites cancer. For most common cancers diagnosed from 2005 to 2009, age-standardized 5-year net survival was: colon-rectum - males 65%, females 65%; lung - males 15%, females 19%; breast 87%; prostate 91%. For cancer sites such as stomach, colon, rectum, lung, skin melanoma, breast, cervix, prostate, and kidney, 5-year net survival is consistent between Central and Northern Italy, while it is a few percentage points lower in Southern Italy. Funnel plots expose these differences more in detail by showing the survival estimates in 13 Italian regions. For all sites but skin, 5- and 10-year net survival increased by about 10 percentage points in men and 7 points in women from 1994 to 2011.DISCUSSION: Specific articles deal with results on solid and haematological malignancies, international comparisons and analysis of time trends of incidence, mortality, and survival in combination for key cancer sites, aiming to interpret overall progress in the control of cancer in Italy.
Original languageItalian
Pages (from-to)1-244
Number of pages244
JournalEpidemiologia e prevenzione
Volume41
Issue number2S1
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Italy
Survival
Neoplasms
Rectum
Prostate
Colon
Breast
Lung
Skin
Hematologic Neoplasms
Life Expectancy
Cervix Uteri
Population
Registries
Melanoma
Stomach
Kidney
Mortality
Incidence

Keywords

  • Journal Article

Cite this

La sopravvivenza dei pazienti oncologici in Italia : Survival of cancer patients in Italy. / Coviello, Vincenzo; Buzzoni, Carlotta; Fusco, Mario; Barchielli, Alessandro; Cuccaro, Francesco; De Angelis, Roberta; Giacomin, Adriano; Luminari, Stefano; Randi, Giorgia; Mangone, Lucia; Group, AIRTUM Working; Filiberti, Rosa.

In: Epidemiologia e prevenzione, Vol. 41, No. 2S1, 01.06.2017, p. 1-244.

Research output: Contribution to journalArticle

Coviello, V, Buzzoni, C, Fusco, M, Barchielli, A, Cuccaro, F, De Angelis, R, Giacomin, A, Luminari, S, Randi, G, Mangone, L, Group, AIRTUMW & Filiberti, R 2017, 'La sopravvivenza dei pazienti oncologici in Italia: Survival of cancer patients in Italy', Epidemiologia e prevenzione, vol. 41, no. 2S1, pp. 1-244. https://doi.org/10.19191/EP17.2S1.P001.017
Coviello V, Buzzoni C, Fusco M, Barchielli A, Cuccaro F, De Angelis R et al. La sopravvivenza dei pazienti oncologici in Italia: Survival of cancer patients in Italy. Epidemiologia e prevenzione. 2017 Jun 1;41(2S1):1-244. https://doi.org/10.19191/EP17.2S1.P001.017
Coviello, Vincenzo ; Buzzoni, Carlotta ; Fusco, Mario ; Barchielli, Alessandro ; Cuccaro, Francesco ; De Angelis, Roberta ; Giacomin, Adriano ; Luminari, Stefano ; Randi, Giorgia ; Mangone, Lucia ; Group, AIRTUM Working ; Filiberti, Rosa. / La sopravvivenza dei pazienti oncologici in Italia : Survival of cancer patients in Italy. In: Epidemiologia e prevenzione. 2017 ; Vol. 41, No. 2S1. pp. 1-244.
@article{9e3ab067ab0341ac9ef3e964350d12eb,
title = "La sopravvivenza dei pazienti oncologici in Italia: Survival of cancer patients in Italy",
abstract = "OBJECTIVES: Population-based survival statistics are fundamental to assess the efficacy of services offered to improve cancer patients' prognosis. This study aims to update cancer survival estimates for the Italian population, as well as provide new measures, such as the crude probability of death, which takes into account the possibility of dying from causes other than cancer, and the change in life expectancy after a cancer diagnosis, to properly address various questions.RESULTS: The study includes 1,932,450 cancer cases detected by the Network of Italian Cancer Registries (AIRTUM) from 1994 to 2011 and provides estimates for 38 cancer sites and for allsites cancer. For most common cancers diagnosed from 2005 to 2009, age-standardized 5-year net survival was: colon-rectum - males 65{\%}, females 65{\%}; lung - males 15{\%}, females 19{\%}; breast 87{\%}; prostate 91{\%}. For cancer sites such as stomach, colon, rectum, lung, skin melanoma, breast, cervix, prostate, and kidney, 5-year net survival is consistent between Central and Northern Italy, while it is a few percentage points lower in Southern Italy. Funnel plots expose these differences more in detail by showing the survival estimates in 13 Italian regions. For all sites but skin, 5- and 10-year net survival increased by about 10 percentage points in men and 7 points in women from 1994 to 2011.DISCUSSION: Specific articles deal with results on solid and haematological malignancies, international comparisons and analysis of time trends of incidence, mortality, and survival in combination for key cancer sites, aiming to interpret overall progress in the control of cancer in Italy.",
keywords = "Journal Article",
author = "Vincenzo Coviello and Carlotta Buzzoni and Mario Fusco and Alessandro Barchielli and Francesco Cuccaro and {De Angelis}, Roberta and Adriano Giacomin and Stefano Luminari and Giorgia Randi and Lucia Mangone and Group, {AIRTUM Working} and Rosa Filiberti",
year = "2017",
month = "6",
day = "1",
doi = "10.19191/EP17.2S1.P001.017",
language = "Italian",
volume = "41",
pages = "1--244",
journal = "Epidemiologia e prevenzione",
issn = "1120-9763",
publisher = "Zadig s.r.l",
number = "2S1",

}

TY - JOUR

T1 - La sopravvivenza dei pazienti oncologici in Italia

T2 - Survival of cancer patients in Italy

AU - Coviello, Vincenzo

AU - Buzzoni, Carlotta

AU - Fusco, Mario

AU - Barchielli, Alessandro

AU - Cuccaro, Francesco

AU - De Angelis, Roberta

AU - Giacomin, Adriano

AU - Luminari, Stefano

AU - Randi, Giorgia

AU - Mangone, Lucia

AU - Group, AIRTUM Working

AU - Filiberti, Rosa

PY - 2017/6/1

Y1 - 2017/6/1

N2 - OBJECTIVES: Population-based survival statistics are fundamental to assess the efficacy of services offered to improve cancer patients' prognosis. This study aims to update cancer survival estimates for the Italian population, as well as provide new measures, such as the crude probability of death, which takes into account the possibility of dying from causes other than cancer, and the change in life expectancy after a cancer diagnosis, to properly address various questions.RESULTS: The study includes 1,932,450 cancer cases detected by the Network of Italian Cancer Registries (AIRTUM) from 1994 to 2011 and provides estimates for 38 cancer sites and for allsites cancer. For most common cancers diagnosed from 2005 to 2009, age-standardized 5-year net survival was: colon-rectum - males 65%, females 65%; lung - males 15%, females 19%; breast 87%; prostate 91%. For cancer sites such as stomach, colon, rectum, lung, skin melanoma, breast, cervix, prostate, and kidney, 5-year net survival is consistent between Central and Northern Italy, while it is a few percentage points lower in Southern Italy. Funnel plots expose these differences more in detail by showing the survival estimates in 13 Italian regions. For all sites but skin, 5- and 10-year net survival increased by about 10 percentage points in men and 7 points in women from 1994 to 2011.DISCUSSION: Specific articles deal with results on solid and haematological malignancies, international comparisons and analysis of time trends of incidence, mortality, and survival in combination for key cancer sites, aiming to interpret overall progress in the control of cancer in Italy.

AB - OBJECTIVES: Population-based survival statistics are fundamental to assess the efficacy of services offered to improve cancer patients' prognosis. This study aims to update cancer survival estimates for the Italian population, as well as provide new measures, such as the crude probability of death, which takes into account the possibility of dying from causes other than cancer, and the change in life expectancy after a cancer diagnosis, to properly address various questions.RESULTS: The study includes 1,932,450 cancer cases detected by the Network of Italian Cancer Registries (AIRTUM) from 1994 to 2011 and provides estimates for 38 cancer sites and for allsites cancer. For most common cancers diagnosed from 2005 to 2009, age-standardized 5-year net survival was: colon-rectum - males 65%, females 65%; lung - males 15%, females 19%; breast 87%; prostate 91%. For cancer sites such as stomach, colon, rectum, lung, skin melanoma, breast, cervix, prostate, and kidney, 5-year net survival is consistent between Central and Northern Italy, while it is a few percentage points lower in Southern Italy. Funnel plots expose these differences more in detail by showing the survival estimates in 13 Italian regions. For all sites but skin, 5- and 10-year net survival increased by about 10 percentage points in men and 7 points in women from 1994 to 2011.DISCUSSION: Specific articles deal with results on solid and haematological malignancies, international comparisons and analysis of time trends of incidence, mortality, and survival in combination for key cancer sites, aiming to interpret overall progress in the control of cancer in Italy.

KW - Journal Article

U2 - 10.19191/EP17.2S1.P001.017

DO - 10.19191/EP17.2S1.P001.017

M3 - Articolo

VL - 41

SP - 1

EP - 244

JO - Epidemiologia e prevenzione

JF - Epidemiologia e prevenzione

SN - 1120-9763

IS - 2S1

ER -